Related Experiment Video
Updated: Jul 14, 2026
A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
Limiting the usage of blood products in cardiovascular surgery
P E Horowitz1, C M Lorenzen, R D Rhydderch
1Department of Anesthesia and Blood Bank, Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Insights
A new blood conservation program significantly reduced blood product use in cardiovascular surgery patients. This initiative lowered overall usage by 29% and donor exposure by 53% despite increased surgical volume.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Patient Blood Management
Background:
- Blood product administration in major cardiovascular surgery is associated with potential complications.
- Optimizing blood product utilization is crucial for patient safety and resource management.
Purpose of the Study:
- To evaluate the impact of a five-part blood component conservation program on blood product utilization.
- To assess the effectiveness of guidelines in reducing blood product exposure and associated complications.
Main Methods:
- Implementation of a comprehensive, multi-component blood conservation program.
- Encouraging adherence to evidence-based guidelines for blood product administration.
- Monitoring blood product utilization (packed red cells, fresh frozen plasma, platelets, cryoprecipitate) and donor exposure per patient.
Main Results:
- Overall blood product utilization decreased by 29%.
- Despite a 46% increase in surgical caseload, patient blood management was improved.
- Donor exposure per patient decreased by 53%.
Conclusions:
- The implemented blood conservation program effectively reduced blood product usage and donor exposure in major cardiovascular surgery.
- Adherence to conservation guidelines is key to minimizing complications and optimizing resource allocation in transfusion medicine.
Abstract:
We studied the effect of the initiation of a five part program of blood component conservation on blood product utilization in patients undergoing major cardiovascular surgery. We encouraged physicians and nurses to adhere to a set of guidelines that would limit the exposure of these patients to complications associated with blood product administration. Through this effort the amounts of packed red cells, fresh frozen plasma, platelets, and cryoprecipitate used were markedly reduced. After the start of the conservation program, overall blood product usage was reduced 29% despite a 46% increase in the surgical caseload, and there was a 53% decrease in the amount of donor exposure (units of individual blood products administered) per patient.
Related Concept Videos
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...